Agios Pharmaceuticals, Inc. (AGIO) is a publicly traded Healthcare sector company. As of May 21, 2026, AGIO trades at $28.50 with a market cap of $1.68B and a P/E ratio of -3.93. AGIO moved +2.72% today. Year to date, AGIO is +3.83%; over the trailing twelve months it is -5.54%. Its 52-week range spans $22.24 to $62.58. Analyst consensus is buy with an average price target of $39.40. Rallies surfaces AGIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded AGIO stock?
Recent politician trading activity in AGIO includes disclosures from Gil Cisneros and Gil Cisneros. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
AGIO Key Metrics
Key financial metrics for AGIO
Metric
Value
Price
$28.50
Market Cap
$1.68B
P/E Ratio
-3.93
EPS
$-7.25
Dividend Yield
0.00%
52-Week High
$62.58
52-Week Low
$22.24
Volume
523.34K
Avg Volume
0
Revenue (TTM)
$66.05M
Net Income
$-422.60M
Gross Margin
90.04%
Congressional Trades in AGIO
Gil Cisneros purchase AGIO on Apr 17, 2025 (amount: $15.00K).
Gil Cisneros purchase AGIO on Jan 29, 2025 (amount: $15.00K).
Recent politician trading activity in AGIO includes disclosures from Gil Cisneros and Gil Cisneros. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in AGIO?
Yes. Rallies tracks politician and congressional stock disclosures for AGIO, including reported purchases, sales, dates, owners, and trade amounts when available.
Is AGIO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AGIO. It does not provide personalized investment advice.
